D-22 | Trajectories of Patients Treated With Beta Blockers and Calcium Channel Blockers for Stable Ischemic Heart Disease and Diabetes Mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial)
Jamil Y, Park D, Chongthammakun V, Al Damluji A, Nanna M. D-22 | Trajectories of Patients Treated With Beta Blockers and Calcium Channel Blockers for Stable Ischemic Heart Disease and Diabetes Mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial). Journal Of The Society For Cardiovascular Angiography & Interventions 2023, 2: 100876. DOI: 10.1016/j.jscai.2023.100876.Peer-Reviewed Original ResearchD-24 | Quality of Life After Revascularization versus Medical Therapy in Older Adults With Stable Ischemic Heart Disease at 5 Year Follow-up in the BARI2D Trial
Park D, Jamil Y, Chongthammakun V, Nanna M, Al Damluji A. D-24 | Quality of Life After Revascularization versus Medical Therapy in Older Adults With Stable Ischemic Heart Disease at 5 Year Follow-up in the BARI2D Trial. Journal Of The Society For Cardiovascular Angiography & Interventions 2023, 2: 100878. DOI: 10.1016/j.jscai.2023.100878.Peer-Reviewed Original ResearchCarcinoid Heart Disease-Induced Right-Sided Heart Failure as a Culprit for Significant Ascites
Huang Y, Park D, Almoghrabi A, Nanna M. Carcinoid Heart Disease-Induced Right-Sided Heart Failure as a Culprit for Significant Ascites. Case Reports In Gastroenterology 2023, 17: 179-184. PMID: 36974060, PMCID: PMC10039415, DOI: 10.1159/000529633.Peer-Reviewed Original ResearchCarcinoid heart diseaseDiagnosis of carcinoid heart diseaseManagement of carcinoid heart diseaseSerum-ascites albumin gradientHeart diseaseAlcohol use disorderSignificant ascitesNeuroendocrine neoplasmsPortal hypertensionCase reportAlbumin gradientHeart failurePhysical examinationEarly diagnosisUse disorderAscitesFluid analysisPatient outcomesPeritoneal fluid analysisDiagnosisMultidisciplinary approachPatientsEarly interventionDiseaseRelevant specialists